EU pharma reform urgently needed, says MEP Montserrat. Critics warn it falls short

EU PERSPECTIVES - As trilogue negotiations near, the EU Council's long-awaited position on the pharmaceutical package is enjoying a cautious welcome as a step forward. But for many policymakers and industry stakeholders, it does not go far enough. While some applaud progress in aligning incentives with public value, others warn the deal still lacks the ambition needed to strengthen Europe's global standing in pharmaceutical innovation. Read more

MEP Dolors Montserrat (EPP/ES) calls for pharmaceutical reform / Photo: EP